In patients with hemophilia A, intensive treatment with factor VIII (FVIII) has been associated with FVIII inhibitor development, which is a severe complication that leads to increased postoperative surgery-related and hematological complications and mortality10. This evidence concerns the gene F8 and hemophilia A.